Free Trial
Notice: This company recently went public with an IPO on Friday, October 11th 2024. They issued 12,500,000 shares at $15.00-$17.00 per share. We will continue to update data for UPB as it becomes available.

Upstream Bio (UPB) SEC Filings & 10K Form

$23.60
-0.03 (-0.13%)
(As of 10/17/2024 ET)

Recent Upstream Bio SEC Filings

DateFilerForm TypeView
10/17/2024
3:16 PM
ORBIMED ADVISORS LLC (Filed by)
Upstream Bio (Subject)
Form SC 13D
10/17/2024
3:17 PM
OrbiMed Advisors Israel II Ltd (Reporting)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VIII LLC (Reporting)
OrbiMed Israel GP II, L.P. (Reporting)
Upstream Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/17/2024
3:19 PM
Chimovits Erez (Reporting)
Upstream Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
6:21 PM
Upstream Bio (Issuer)
Wellington Biomedical Innovation Master Investors II L.P. (0001903360) (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
3:15 PM
Ratcliffe Liam (Reporting)
Upstream Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
3:15 PM
Beckman Daniella (Reporting)
Upstream Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
3:15 PM
Fleming Harold Edward (Reporting)
Upstream Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
3:15 PM
Renaud Ronald C JR (Reporting)
Upstream Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
3:15 PM
Ruddy Marcella K. (Reporting)
Upstream Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
3:15 PM
Chimovits Erez (Reporting)
Upstream Bio (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
3:05 PM
Upstream Bio (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2024
3:05 PM
Upstream Bio (Filer)
Form 424B4
10/10/2024
11:15 PM
Upstream Bio (Filer)
Form EFFECT
10/10/2024
7:48 PM
Upstream Bio (Issuer)
Wellington Biomedical Innovation Master Investors II L.P. (0001903360) (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/10/2024
7:19 PM
Houghton Adam (Reporting)
Upstream Bio (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/10/2024
7:25 PM
Beckman Daniella (Reporting)
Upstream Bio (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/10/2024
7:33 PM
Chimovits Erez (Reporting)
Upstream Bio (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/10/2024
7:42 PM
Sutherland Everett Rand (Reporting)
Upstream Bio (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/10/2024
7:09 PM
GRAY MICHAEL (Reporting)
Upstream Bio (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/10/2024
7:09 PM
Renaud Ronald C JR (Reporting)
Upstream Bio (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/10/2024
7:09 PM
OrbiMed Advisors Israel II Ltd (Reporting)
ORBIMED ADVISORS LLC (Reporting)
OrbiMed Capital GP VIII LLC (Reporting)
OrbiMed Israel GP II, L.P. (Reporting)
Upstream Bio (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/10/2024
7:10 PM
Fleming Harold Edward (Reporting)
Upstream Bio (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/10/2024
7:12 PM
Deykin Aaron (Reporting)
Upstream Bio (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/10/2024
7:14 PM
Ratcliffe Liam (Reporting)
Upstream Bio (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/10/2024
7:14 PM
Ruddy Marcella K. (Reporting)
Upstream Bio (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/10/2024
5:59 PM
Upstream Bio (Filer)
Form S-1MEF
10/10/2024
3:27 PM
Access Industries Holdings LLC (Reporting)
ACCESS INDUSTRIES MANAGEMENT, LLC (Reporting)
AI Biotechnology LLC (Reporting)
AI Upstream LLC (Reporting)
Blavatnik Len (Reporting)
Upstream Bio (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
10/10/2024
1:02 PM
Upstream Bio (Filer)
Form CERT
10/08/2024
3:05 PM
Upstream Bio (Filer)
Form 8-A12B
10/07/2024
5:08 AM
Upstream Bio (Filer)
Form S-1/A
09/18/2024
3:06 PM
Upstream Bio (Filer)
Form S-1
Registration statement under Securities Act of 1933  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:UPB) was last updated on 10/18/2024 by MarketBeat.com Staff
From Our Partners